Albemarle has agreed to sell its ibuprofen business to US chemical intermediates firm SI Group in a deal that will also see it divest the anaesthetic agent, propofol.
SCOLR Pharma has initiated the first of three pivotal trials to
evaluate its extended release ibuprofen tablet, with hopes that it
will be the first and only 12-hour formulation on the market.
Granules India and Biocause have signed an agreement to create a 50
: 50 joint venture entity to manufacture and sell pharmaceutical
APIs (Active Pharmaceutical Ingredients), starting with Ibuprofen.
Chemical firm BASF has announced it has developed a new formulation
for its Ibuprofen DC 85, an active substance in anti-inflammatory
and analgesic products, using a nanocoating which, thanks to its
resistance to high temperature,...
French drug delivery specialist Ethypharm has won a contract to
apply its melt-in-the-mouth Flashtab technology to two new
over-the-counter analgesic products that will be marketed in Japan
by Kowa.
